Intelligence
Home / Industry Impact Series
Trinity Life Sciences is proud to announce our Industry Impact Series, a thought leadership series that identifies key issues that will revolutionize the way therapeutics are developed and commercialized in the years ahead. The focus of Trinity’s Industry Impact Series explores how biopharma can reimagine the blockbuster and translate scientific innovation to commercial success. The series is designed to leverage the totality of Trinity’s background as a life sciences partner supporting strategy, insights and analytics across the product lifecycle.
Picking Winners: Portfolio Management for a New Era
The biopharmaceutical industry is known for its promise of life-changing innovations, but many companies continue to advance the wrong therapies into the clinic, resulting in underperformance and wasted resources. This white paper explores the concentration of activity on well-trodden ground, and the lack of focus on true innovation. With increasing global pricing pressures and policy changes, it is more important than ever to be selective about the drugs that are advanced into the market. This white paper offers insights and recommendations for transforming patient outcomes and achieving commercial success in a challenging landscape.
Predicting Winners: AI-Powered Portfolio Management
Can artificial intelligence and machine learning (AIML) be used to support portfolio decision-making across the life sciences industry?
In this installment of our Industry Impact Series, we find that not only can the latest AIML techniques identify the drivers of success and failure in commercialization, but Trinity Life Sciences’ AI algorithm accurately predicts revenue outcomes for >90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%).
Sign up for the latest intelligence
By signing up, you are agreeing to our Privacy Policy.
We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.